Search
Lilly lowers the price of Zepbound® (tirzepatide) single-dose vials
December 1, 2025 - … Lilly lowers the price of Zepbound® (tirzepatide) single-dose vials Lilly lowers the price of Zepbound® (tirzepatide) single-dose vials December 1, 2025 Product … -- Eli Lilly and Company (NYSE: LLY) announced Zepbound ® (tirzepatide) single-dose vials will now be available at lower …
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans
November 6, 2025 - … will pay no more than $50 per month for Zepbound (tirzepatide), available in a multi-dose pen, and for … (galcanezumab-gnlm), Trulicity (dulaglutide) and Mounjaro (tirzepatide) will be added to LillyDirect and made available … diet and increased physical activity. Zepbound contains tirzepatide and should not be used with other …
Statement: Eli Lilly has no affiliation with Mangoceuticals, Inc.
November 13, 2025 - … and send valid, on-label prescriptions for Zepbound (tirzepatide) single-dose vials directly to LillyDirect Self … and send valid, on-label prescriptions for Zepbound (tirzepatide) single-dose vials directly to LillyDirect Self … and send valid, on-label prescriptions for Zepbound (tirzepatide) single-dose vials directly to LillyDirect Self …
Queer Eye's Tan France helps unthread obesity bias as part of Zepbound's (tirzepatide) 'Changing the Thread Collection'
November 10, 2025 - … France helps unthread obesity bias as part of Zepbound's (tirzepatide) 'Changing the Thread Collection' Queer Eye's Tan … France helps unthread obesity bias as part of Zepbound's (tirzepatide) 'Changing the Thread Collection' November 10, …
Lilly's selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight
November 6, 2025 - … evaluating eloralintide, alone or in combination, with tirzepatide for weight management in adults with obesity or … evaluating eloralintide, alone or in combination, with tirzepatide for weight management in adults with obesity or … evaluating eloralintide, alone or in combination, with tirzepatide for weight management in adults with obesity or …
Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance
October 30, 2025 - … in ulcerative colitis ( announcement ) Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C … in ulcerative colitis ( announcement ) Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C … in ulcerative colitis ( announcement ) Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C …
LillyDirect and Walmart Pharmacy launch first retail pick-up option with direct-to-consumer pricing for Zepbound
October 29, 2025 - … expand access to direct-to-consumer pricing for Zepbound (tirzepatide) single-dose vials available through LillyDirect … diet and increased physical activity. Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist …
… Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with … Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with …
Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes
September 17, 2025 - … Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C … and adolescents with type 2 diabetes Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C … 3 trial to evaluate the safety and efficacy of Mounjaro (tirzepatide), a GIP/ GLP-1 dual receptor agonist, in children …
Lilly reports second-quarter 2025 financial results and raises guidance
August 7, 2025 - … in adults with obesity ( announcement ) Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated … the 2025 ASCO Annual Meeting ( announcement ). Zepbound (tirzepatide) showed superior weight loss over Wegovy … ent ). Lilly to offer all approved doses of Zepbound (tirzepatide) single-dose vials through LillyDirect Self Pay …